+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bristol-Myers Squibb - logo

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

From
From
Testicular Cancer Drugs - Global Strategic Business Report - Product Thumbnail Image

Testicular Cancer Drugs - Global Strategic Business Report

  • Report
  • August 2025
  • 269 Pages
  • Global
From
Metastatic Cancer Drugs - Global Strategic Business Report - Product Thumbnail Image

Metastatic Cancer Drugs - Global Strategic Business Report

  • Report
  • August 2025
  • 377 Pages
  • Global
From
From
From
Bortezomib - Global Strategic Business Report - Product Thumbnail Image

Bortezomib - Global Strategic Business Report

  • Report
  • August 2025
  • 377 Pages
  • Global
From
Gastric Cancer - Global Strategic Business Report - Product Thumbnail Image

Gastric Cancer - Global Strategic Business Report

  • Report
  • August 2025
  • 582 Pages
  • Global
From
From
Cytotoxic Drugs - Global Strategic Business Report - Product Thumbnail Image

Cytotoxic Drugs - Global Strategic Business Report

  • Report
  • August 2025
  • 462 Pages
  • Global
From
Cellular Immunotherapy - Global Strategic Business Report - Product Thumbnail Image

Cellular Immunotherapy - Global Strategic Business Report

  • Report
  • August 2025
  • 386 Pages
  • Global
From
Cancer Biological Therapy - Global Strategic Business Report - Product Thumbnail Image

Cancer Biological Therapy - Global Strategic Business Report

  • Report
  • August 2025
  • 211 Pages
  • Global
From
Epithelioma Treatment - Global Strategic Business Report - Product Thumbnail Image

Epithelioma Treatment - Global Strategic Business Report

  • Report
  • August 2025
  • 380 Pages
  • Global
From
Esophageal Cancer Drugs - Global Strategic Business Report - Product Thumbnail Image

Esophageal Cancer Drugs - Global Strategic Business Report

  • Report
  • August 2025
  • 269 Pages
  • Global
From
From
Blood Cancer Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Blood Cancer Therapeutics - Global Strategic Business Report

  • Report
  • August 2025
  • 291 Pages
  • Global
From
Orphan Drugs - Global Strategic Business Report - Product Thumbnail Image

Orphan Drugs - Global Strategic Business Report

  • Report
  • August 2025
  • 409 Pages
  • Global
From
From
From
Loading Indicator